Rocket Pharmaceuticals, Inc. Common Stock (RCKT) is a publicly traded Healthcare sector company. As of November 12, 2026, RCKT trades at $2.40 with a market cap of $272.24M and a P/E ratio of -1.29. RCKT moved -3.63% today. Year to date, RCKT is -32.54%; over the trailing twelve months it is -27.42%. Its 52-week range spans $2.17 to $8.80. Analyst consensus is buy with an average price target of $9.50. Rallies surfaces RCKT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for RCKT combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $2.40 |
| Market Cap | $272.24M |
| P/E Ratio | -1.29 |
| EPS | $-2.01 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.80 |
| 52-Week Low | $2.17 |
| Volume | 804.17K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-223.12M |
| Gross Margin | 0.00% |
11 analysts cover RCKT: 0 strong buy, 7 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.50.